Related Experiment Videos
Generative adversarial networks and hyperparameter-optimized XGBoost for enhanced heart disease prediction.
Shaik Sajeera Begum1, Amit Swamy1, Sanjay Dhanka2
1School of Technology, Woxsen University, Hyderabad, India.
Scientific Reports
|February 26, 2026
Summary
A new hybrid framework, GAN-XO, improves early heart disease (HD) detection by addressing data quality issues. This system enhances diagnostic accuracy for better clinical decision-making and reliable patient identification.
Area of Science:
- Cardiology
- Artificial Intelligence
- Data Science
Background:
- Heart disease (HD) is a leading global cause of mortality, necessitating advanced diagnostic tools.
- Clinical data often suffers from bias and noise, hindering the development of reliable predictive models for early HD detection.
Purpose of the Study:
- To propose and evaluate a novel hybrid framework, GAN-XO, for early detection of heart disease.
- To address data imbalance and noise in clinical datasets for improved predictive model performance.
Main Methods:
- Utilized a Generative Adversarial Network (GAN) for synthetic oversampling to balance imbalanced datasets.
- Implemented a two-phase outlier detection and elimination process (z-score and IQR) for data cleaning.
- Employed an XGBoost classifier with hyperparameter optimization via Optuna for accurate prediction.
Main Results:
- The GAN-XO system achieved a high accuracy of 96.60% and an F1-Score of 0.9649 on a clean, balanced test dataset.
- Ablation studies confirmed the contribution of each component, highlighting the critical role of outlier elimination.
- The framework demonstrated significant performance enhancement, improving trustworthiness and model reliability.
Conclusions:
- Accurate healthcare predictions depend on integrated modeling systems and rigorous data quality management.
- The GAN-XO framework offers a promising approach to enhance clinical decision-making for early heart disease diagnosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
998
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
998
Heart Failure Drugs: β-Blockers
1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K